Loss-of-function test on SFRP1 in triple negative breast cancer modified the tumorigenic properties of the cells through pro-apoptotic and migratory pathways but did not rely on Wnt signaling. This evidence concerns the gene SFRP1 and triple-negative breast carcinoma.